MeSH term
Frequency | Condition_Probility | Aged | 6 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Female | 10 | 0.0 |
Humans | 30 | 0.0 |
Male | 12 | 0.0 |
Middle Aged | 9 | 0.0 |
Research Support, Non-U.S. Gov't | 23 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Adolescent | 6 | 0.0 |
*Chromosomes, Human, Pair 16 | 8 | 3.0 |
*Gene Deletion | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 5 | 0.0 |
*Inversion, Chromosome | 14 | 18.0 |
Leukemia, Myelomonocytic, Acute/*genetics | 4 | 16.0 |
Adult | 9 | 0.0 |
DNA-Binding Proteins/*genetics | 4 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
*Proto-Oncogene Proteins | 7 | 0.0 |
Recurrence | 2 | 0.0 |
Transcription Factors/*genetics | 5 | 0.0 |
Animals | 12 | 0.0 |
DNA-Binding Proteins/*physiology | 2 | 0.0 |
*Drosophila Proteins | 2 | 0.0 |
*Hematopoiesis | 2 | 1.0 |
Mice | 8 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
Transcription Factors/*physiology | 2 | 0.0 |
Heterozygote | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Leukemia, Myelocytic, Acute/*genetics | 3 | 2.0 |
Transcription, Genetic | 3 | 0.0 |
Chromosomes, Human, Pair 16 | 3 | 2.0 |
Cytogenetic Analysis | 2 | 1.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Transcription Factors/genetics | 2 | 0.0 |
Translocation, Genetic | 3 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Chromosomes, Human, Pair 16/*genetics | 3 | 3.0 |
Comparative Study | 2 | 0.0 |
DNA/metabolism | 3 | 0.0 |
Hematopoiesis/*genetics | 3 | 5.0 |
Protein Binding | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
*Neoplasm Proteins | 4 | 0.0 |
Child, Preschool | 2 | 0.0 |
Karyotyping | 2 | 0.0 |
Child | 2 | 0.0 |
*Translocation, Genetic | 3 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Protein Conformation | 2 | 0.0 |
Eosinophils/pathology | 2 | 5.0 |
Acute Disease | 6 | 0.0 |
Base Sequence | 8 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
*Gene Rearrangement | 2 | 0.0 |
Oncogene Proteins, Fusion/*genetics | 3 | 1.0 |
Polymerase Chain Reaction | 6 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Exons | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
Transcription Factors/biosynthesis/*genetics | 2 | 1.0 |
Myosins/*genetics | 2 | 3.0 |
